223 related articles for article (PubMed ID: 32039379)
1. Mechanistic insights into the inhibition of NTCP by myrcludex B.
Donkers JM; Appelman MD; van de Graaf SFJ
JHEP Rep; 2019 Oct; 1(4):278-285. PubMed ID: 32039379
[TBL] [Abstract][Full Text] [Related]
2. Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
Donkers JM; Zehnder B; van Westen GJP; Kwakkenbos MJ; IJzerman AP; Oude Elferink RPJ; Beuers U; Urban S; van de Graaf SFJ
Sci Rep; 2017 Nov; 7(1):15307. PubMed ID: 29127322
[TBL] [Abstract][Full Text] [Related]
3. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
[TBL] [Abstract][Full Text] [Related]
4. Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice.
Slijepcevic D; Roscam Abbing RLP; Katafuchi T; Blank A; Donkers JM; van Hoppe S; de Waart DR; Tolenaars D; van der Meer JHM; Wildenberg M; Beuers U; Oude Elferink RPJ; Schinkel AH; van de Graaf SFJ
Hepatology; 2017 Nov; 66(5):1631-1643. PubMed ID: 28498614
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Nkongolo S; Ni Y; Lempp FA; Kaufman C; Lindner T; Esser-Nobis K; Lohmann V; Mier W; Mehrle S; Urban S
J Hepatol; 2014 Apr; 60(4):723-31. PubMed ID: 24295872
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
Bogomolov P; Alexandrov A; Voronkova N; Macievich M; Kokina K; Petrachenkova M; Lehr T; Lempp FA; Wedemeyer H; Haag M; Schwab M; Haefeli WE; Blank A; Urban S
J Hepatol; 2016 Sep; 65(3):490-8. PubMed ID: 27132170
[TBL] [Abstract][Full Text] [Related]
8. Long-term
Lowjaga KAAT; Kirstgen M; Müller SF; Goldmann N; Lehmann F; Glebe D; Geyer J
Am J Physiol Gastrointest Liver Physiol; 2021 Jan; 320(1):G66-G80. PubMed ID: 33174454
[TBL] [Abstract][Full Text] [Related]
9. Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice.
Slijepcevic D; Kaufman C; Wichers CG; Gilglioni EH; Lempp FA; Duijst S; de Waart DR; Elferink RP; Mier W; Stieger B; Beuers U; Urban S; van de Graaf SF
Hepatology; 2015 Jul; 62(1):207-19. PubMed ID: 25641256
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity.
Donkers JM; Roscam Abbing RLP; van Weeghel M; Levels JHM; Boelen A; Schinkel AH; Oude Elferink RPJ; van de Graaf SFJ
Cell Mol Gastroenterol Hepatol; 2020; 10(3):451-466. PubMed ID: 32330730
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
[TBL] [Abstract][Full Text] [Related]
12. Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP.
Liu H; Zakrzewicz D; Nosol K; Irobalieva RN; Mukherjee S; Bang-Sørensen R; Goldmann N; Kunz S; Rossi L; Kossiakoff AA; Urban S; Glebe D; Geyer J; Locher KP
Nat Commun; 2024 Mar; 15(1):2476. PubMed ID: 38509088
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis D Virus Entry Inhibitors Based on Repurposing Intestinal Bile Acid Reabsorption Inhibitors.
Kirstgen M; Lowjaga KAAT; Müller SF; Goldmann N; Lehmann F; Glebe D; Baringhaus KH; Geyer J
Viruses; 2021 Apr; 13(4):. PubMed ID: 33921515
[TBL] [Abstract][Full Text] [Related]
14. Interactions of Na
Zakrzewicz D; Geyer J
Biol Chem; 2023 Jun; 404(7):673-690. PubMed ID: 37103224
[TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide.
Yan H; Peng B; He W; Zhong G; Qi Y; Ren B; Gao Z; Jing Z; Song M; Xu G; Sui J; Li W
J Virol; 2013 Jul; 87(14):7977-91. PubMed ID: 23678176
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine 146 of the Human Na
Zakrzewicz D; Leidolf R; Kunz S; Müller SF; Neubauer A; Leiting S; Goldmann N; Lehmann F; Glebe D; Geyer J
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746730
[TBL] [Abstract][Full Text] [Related]
17. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
[TBL] [Abstract][Full Text] [Related]
18. Clinical effects of NTCP-inhibitor myrcludex B.
Cheng D; Han B; Zhang W; Wu W
J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010
[TBL] [Abstract][Full Text] [Related]
19. Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.
Appelman MD; Wettengel JM; Protzer U; Oude Elferink RPJ; van de Graaf SFJ
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158960. PubMed ID: 33932583
[TBL] [Abstract][Full Text] [Related]
20. Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
Veloso Alves Pereira I; Buchmann B; Sandmann L; Sprinzl K; Schlaphoff V; Döhner K; Vondran F; Sarrazin C; Manns MP; Pinto Marques Souza de Oliveira C; Sodeik B; Ciesek S; von Hahn T
PLoS One; 2015; 10(2):e0117152. PubMed ID: 25646622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
